These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 20964335)

  • 1. Targeted delivery of siRNA to hepatocytes and hepatic stellate cells by bioconjugation.
    Zhu L; Mahato RI
    Bioconjug Chem; 2010 Nov; 21(11):2119-27. PubMed ID: 20964335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocyte-targeted psiRNA delivery mediated by galactosylated poly(ethylene glycol)-graft-polyethylenimine in vitro.
    Nie C; Liu C; Chen G; Dai J; Li H; Shuai X
    J Biomater Appl; 2011 Sep; 26(3):255-75. PubMed ID: 20511388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemically defined polyethylene glycol siRNA conjugates with enhanced gene silencing effect.
    Gaziova Z; Baumann V; Winkler AM; Winkler J
    Bioorg Med Chem; 2014 Apr; 22(7):2320-6. PubMed ID: 24613624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dicer-labile PEG conjugates for siRNA delivery.
    Kow SC; McCarroll J; Valade D; Boyer C; Dwarte T; Davis TP; Kavallaris M; Bulmus V
    Biomacromolecules; 2011 Dec; 12(12):4301-10. PubMed ID: 22053777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TGF-beta1 gene silencing for treating liver fibrosis.
    Cheng K; Yang N; Mahato RI
    Mol Pharm; 2009; 6(3):772-9. PubMed ID: 19388665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene silencing efficiency of siRNA-PEG conjugates: effect of PEGylation site and PEG molecular weight.
    Jung S; Lee SH; Mok H; Chung HJ; Park TG
    J Control Release; 2010 Jun; 144(3):306-13. PubMed ID: 20206653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new synthesis of galactose-poly(ethylene glycol)-polyethylenimine for gene delivery to hepatocytes.
    Sagara K; Kim SW
    J Control Release; 2002 Feb; 79(1-3):271-81. PubMed ID: 11853937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small interfering RNA delivery into the liver by cationic cholesterol derivative-based liposomes.
    Hattori Y; Machida Y; Honda M; Takeuchi N; Yoshiike Y; Ohno H; Onishi H
    J Liposome Res; 2017 Dec; 27(4):264-273. PubMed ID: 27345333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gremlin1 Accelerates Hepatic Stellate Cell Activation Through Upregulation of TGF-Beta Expression.
    Zhang YQ; Wan LY; He XM; Ni YR; Wang C; Liu CB; Wu JF
    DNA Cell Biol; 2017 Jul; 36(7):603-610. PubMed ID: 28467108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reducible siRNA dimeric conjugates for efficient cellular uptake and gene silencing.
    Chung HJ; Hong CA; Lee SH; Jo SD; Park TG
    Bioconjug Chem; 2011 Feb; 22(2):299-306. PubMed ID: 21222435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of long-circulating cationic nanoparticle formulations consisting of a two-stage PEGylation step for the delivery of siRNA in a breast cancer tumor model.
    Ho EA; Osooly M; Strutt D; Masin D; Yang Y; Yan H; Bally M
    J Pharm Sci; 2013 Jan; 102(1):227-36. PubMed ID: 23132529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Site-specific delivery of oligonucleotides to hepatocytes after systemic administration.
    Zhu L; Ye Z; Cheng K; Miller DD; Mahato RI
    Bioconjug Chem; 2008 Jan; 19(1):290-8. PubMed ID: 17850109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ethanol-stimulated differentiated functions of human or mouse hepatic stellate cells are mediated by connective tissue growth factor.
    Chen L; Charrier AL; Leask A; French SW; Brigstock DR
    J Hepatol; 2011 Aug; 55(2):399-406. PubMed ID: 21156189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HPMA polymer-based site-specific delivery of oligonucleotides to hepatic stellate cells.
    Yang N; Ye Z; Li F; Mahato RI
    Bioconjug Chem; 2009 Feb; 20(2):213-21. PubMed ID: 19133717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient and Tumor Targeted siRNA Delivery by Polyethylenimine-graft-polycaprolactone-block-poly(ethylene glycol)-folate (PEI-PCL-PEG-Fol).
    Liu L; Zheng M; Librizzi D; Renette T; Merkel OM; Kissel T
    Mol Pharm; 2016 Jan; 13(1):134-43. PubMed ID: 26641134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poly(DMAEMA-NVP)-b-PEG-galactose as gene delivery vector for hepatocytes.
    Lim DW; Yeom YI; Park TG
    Bioconjug Chem; 2000; 11(5):688-95. PubMed ID: 10995213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGF-beta1 down-regulates connexin 43 expression and gap junction intercellular communication in rat hepatic stellate cells.
    Lim MC; Maubach G; Zhuo L
    Eur J Cell Biol; 2009 Dec; 88(12):719-30. PubMed ID: 19781809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel in vivo siRNA delivery system specifically targeting liver cells for protection of ConA-induced fulminant hepatitis.
    Jiang N; Zhang X; Zheng X; Chen D; Siu K; Wang H; Ichim TE; Quan D; McAlister V; Chen G; Min WP
    PLoS One; 2012; 7(9):e44138. PubMed ID: 22970170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced siRNA delivery using cationic liposomes with new polyarginine-conjugated PEG-lipid.
    Kim HK; Davaa E; Myung CS; Park JS
    Int J Pharm; 2010 Jun; 392(1-2):141-7. PubMed ID: 20347025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PEG conjugated VEGF siRNA for anti-angiogenic gene therapy.
    Kim SH; Jeong JH; Lee SH; Kim SW; Park TG
    J Control Release; 2006 Nov; 116(2):123-9. PubMed ID: 16831481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.